Table 1 Clinical characteristics of colorectal cancer, adenomatous polyp, and control groups

Age (years)

54.56 ± 12.18

52.55 ± 12.16

53.34 ± 14.18

Male (%)

111 (59.7%)

79 (59.8%)

65 (60.2%)

WBC (10⁹/L)

6.77 ± 1.64^a

6.32 ± 1.61

6.23 ± 1.02^c

RBC (10¹²/L)

4.42 ± 0.63^a

4.78 ± 0.72

4.73 ± 0.42^c

Hb (g/L)

121.27 ± 23.07^a

132.12 ± 20.03^b

142.47 ± 11.80^c

Neutrophil (10⁹/L)

3.92 ± 1.26^a

3.57 ± 1.26

3.40 ± 0.79^c

Lymphocyte (10⁹/L)

1.99 ± 0.58

1.99 ± 0.60^b

2.18 ± 0.51^c

Monocyte (10⁹/L)

0.53 ± 0.19

0.50 ± 0.17^b

0.45 ± 0.15^c

Platelet count (10⁹/L)

279.80 ± 80.56^a

223.89 ± 42.59^b

207.83 ± 37.40^c

MPV (fl)

8.48 ± 1.10^a

8.83 ± 0.90

8.98 ± 0.77^c

MPV/PC

0.0330 ± 0.0112^a

0.0411 ± 0.0112^b

0.0447 ± 0.0096^c

NLR

1.98 (1.50–2.51)^a

1.67 (1.37–2.27)^b

1.51 (1.24–1.92)^c

PLR

140.26 (107.11–182.96)^a

113.03(90.98–143.81)^b

94.55 (76.62–116.42)^c